SLC1A5 and neoplasm: Current studies on SLC1A5 in tumor cells have shown that increased SLC1A5 expression promotes glutamine dependence and antioxidant stress, affects the components of immune cell infiltration, and is associated with poor tumor prognosis [22–24].